Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Composition of Optomed’s Nomination Board

Optomed Plc Stock Exchange Release 7 September 2022 at 12.00, Helsinki Composition of Optomed’s Nomination Board The composition of Optomed’s Nomination Board will remain the same as last year. According to Optomed’s shareholder register of 1 September 2022, the shareholders represented in the shareholders’ Nomination Board are OP-Rahastoyhtiö Oy (OP funds), Aktia Rahastoyhtiö Oy (Aktia funds) and Finnish Industry Investment Ltd. These shareholders have appointed the following persons to the Nomination Board:   · Vesa Vanha-Honko, OP funds · Markus Lindqvist, Aktia funds

Dizlin Pharmaceuticals publishes data from pharmacokinetic study (PK) (IPO-001) with Infudopa SubC (DIZ102) and Infudopa IntraV (DIZ101) in Neurology

Gothenburg, Sweden, September 7, 2022 – Dizlin Pharmaceuticals AB, a research-based pharmaceutical development company with focus on diseases of the central nervous system (CNS), announces that an article has been published in Neurology®, from the American Academy of Neurology®, describing data from the company’s IPO-001 pharmacokinetic cross-over study.   · In a pharmacokinetic cross-over study comprising 18 evaluable subjects with advanced Parkinson´s disease, levodopa/carbidopa solutions with a pH of 5.5 were produced by continuous buffering shortly prior to intravenous (DIZ101) or

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

UT Southwestern expands with two WasteLog™ systems

UT Southwestern in Dallas, Texas purchases two additional WasteLog™ systems as part of an expanded program to prevent Drug Diversion. After installation, UT Southwestern will have a total of six WasteLog™ systems.UT Southwestern is one of the premier academic medical centers in the US and is part of Southwestern Health Resources, a hospital network with a total of 29 hospitals and over 650 medical centers. UT Southwestern has an extensive research activity that has generated six Nobel Prizes since 1985. The hospital acquired four WasteLog™ systems in December 2020 for the control of

Visma appoints new Managing Director for Porto tech centre

Visma, one of Europe’s leading software providers, announces the appointment of Eva Martins as Managing Director for its newly established tech centre in the city of Porto, Visma Tech Portugal. As part of Visma’s strategic investments in innovation, Visma Tech Portugal focuses on creating innovative cloud software within accounting, invoicing, procurement, HRM, payroll, and administration for the private and public sectors. Martins began in her new role on September 1st and is setting up and leading the organisation locally in alignment with the strategic direction of Visma Group. “

Record summer for Viking Line on its Turku-Mariehamn-Stockholm route - Viking Glory inspired younger adults to take a cruise

The new Viking Glory enticed a larger share of younger adults to enjoy holiday travel at sea, and an all-time passenger record on the Turku-Mariehamn-Stockholm route was the icing on the cake for Viking Line’s splendid summer.When Viking Glory launched service on the Turku-Mariehamn-Stockholm route in March, the prediction at Viking Line was that the new vessel would lead to an upturn in traffic on the route but also increase interest in Turku, Åland and Stockholm as destinations. That turned out to be the case too, as more than 740,000 people travelled with Viking Glory and Viking Grace

Impero reinforces confidence in internal control setup and receives the important ISAE 3402 Type I audit statement

Copenhagen, September 7, 2022 Reassuring Impero’s customers of the strength of our internal control setup, we continue to emphasize transparency initiatives and have obtained the ISAE 3402 Type I assurance statement performed by Deloitte, one of the industry-leading audit and assurance firms.The ISAE 3402 The International Standard on Assurance Engagements 3402 (ISAE 3402) is an international assurance standard that provides customers and other stakeholders with information on policies, procedures, and controls that may be relevant to their internal control structure and financial

Raisio plc: Raisio's converted shares

Raisio plc  Stock Exchange Release, 7 September 2022   RAISIO'S CONVERTED SHARES   The Board of Directors of Raisio plc has decided in its meeting held on 24 August 2022 to convert a total of 2,858 restricted shares (series K) into free shares (series V). The decision has been entered in the Trade Register today, on 7 September 2022. The additional lot of free shares in question is admitted to trading on the Nasdaq Helsinki Ltd as of 8 September 2022.   Since the beginning of 2022, a total of 46,858 restricted shares of the company have been converted into free shares. The

The European Commission has selected Dicot to compete in the Innovation Radar Prize

Uppsala, September 7, 2022. The European Commission has selected Dicot from thousands of small and medium-sized European companies as one of the companies to participate in the Innovation Radar Prize 2022.Dicot's goal is to drastically change the way of treating erectile dysfunction by developing a new modern potency drug. The company has been noticed by the European Commission, which recently contacted and invited the company to participate in the Innovation Radar Prize 2022. Dicot is thus one of the companies selected in competition with thousands of EU-funded small and medium-sized

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 176 - 7 SEPTEMBER 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

MEKO and Mobivia Fleet Solutions in a partnership agreement around a complete fleet solution

MEKO AB (former Mekonomen Group) and Mobivia Fleet Solutions, a company belonging to Mobivia SA, have signed a Partnership agreement in order to provide fleet customers with a multi-brand fleet solution in Europe. The collaboration offers the fleet customers and also new electric vehicle producers a complete service and full car fleet maintenance in the markets of MEKO and Mobivias networks.   “We are excited to partner with Mobivia Fleet Solutions. With the networks combined, we can develop fleet management, offering companies a unique solution in Central and Northern Europe. This

ABS Approves Ammonia-Fueled Ammonia/LPG Carriers

AIP the Culmination of Pioneering JDP with HHI, EPS and MPA(MILAN) ABS has granted approval in principle (AIP) to Hyundai Heavy Industries (HHI) and Hyundai Mipo Dockyard (HMD) for the concept design of two ammonia-fueled liquefied petroleum gas (LPG) carriers. The 40,000 m3 and 60,000 m3 capacity carriers were developed in cooperation with Korea Shipbuilding & Offshore (KSOE). Awarded at Gastech, the AIP is the completion of phase one of a joint development project (JDP) among ABS, HHI, Eastern Pacific Shipping (EPS) and the Maritime and Port Authority of Singapore (MPA) which was

Enersense has been chosen as the main contractor for Fingrid's Simojoki substation expansion project

Enersense International PlcPress release 7 September 2022 at 10:00 a.m.A subsidiary of Enersense International Plc, a provider of zero-emission energy solutions, Enersense PN Oy, which operates in the business area of Power, has won a contract for the expansion of the Simojoki substation in Fingrid's public procurement tendering. The expansion of the Simojoki substation, located in the municipality of Simo on the border of the regions of Lapland and North Ostrobothnia, will enable new wind farms planned in the vicinity to be connected to the grid. The project is estimated to employ

Development of Fellow Bank's loan and deposit portfolio in August

FELLOW BANK PLC PRESS RELEASE 7.9.2022 AT 10:00 AM EESTIn August 2022, Fellow Bank provided funding worth of EUR 27.1 million. The loan portfolio totaled EUR 134.5 million and deposits totaled EUR 271.0 million at the end of the month. Fellow Bank, which focuses on easy-to-use digital service channels, currently offers flexible financial services for SMEs and personal customers, as well as a competitive and secure return on deposits with savings accounts and time deposits. The service offering will gradually expand during 2022.  Fellow Bank reports on the development of the loan and

Salipro Biotech Obtains Granted Patents in the United States and China for Direct Extraction of Membrane Proteins and Library Generation

Salipro Biotech strengthens its IP portfolio protecting its innovative, proprietary technology to enable the development of therapeutics against challenging drug targets, including GPCR’s, SLCs and Ion Channels. Stockholm, Sweden, September 07, 2022 – Salipro Biotech AB, a Swedish biotech company with a leading technology platform for the stabilization of membrane proteins for drug development, announced today that its patent entitled “Saposin lipoprotein particles and libraries from crude membranes” has been issued by both the U.S. Patent and Trademark Office (U.S. Patent No. 11,346,843B2)

Nordea Economic Outlook: Feeling the Squeeze

The energy crisis has hit the European economy hard, and the risk of a recession in the Euro area is real. Inflation has reached the highest level since the early 1980s, and central banks seem determined to fight it through aggressive monetary policy. This is also the case in the Nordic countries where housing markets face a sharp slowdown, says Helge Pedersen, Nordea Group Chief Economist.   The Nordic economies have recovered strongly from the pandemic but are now being hit by the sharp increase in cost of living and the uncertain economic environment. The common denominator for the

Lena Philipsson to star in Viaplay’s ‘The Street Where I Live’

· Six-part drama inspired by hit song from one of Sweden’s leading musical artists · ‘The Street Where I Live’ created and scripted by Mikael Newihl (‘Max Anger’) at Viaplay Studios, with Viaplay Content Distribution handling global sales · Viaplay to premiere at least 70 Originals in 2022 Lena Philipsson, one of Sweden’s most successful musical artists, will take on her first lead drama role in the Viaplay Original ‘The Street Where I Live’. Philipsson has had no fewer than 13 albums in the country’s top 20-chart since her debut in 1984, and represented Sweden in the 2004

Salipro Biotech Obtains Granted Patents in the United States and China for Direct Extraction of Membrane Proteins and Library Generation

Salipro Biotech strengthens its IP portfolio protecting its innovative, proprietary technology to enable the development of therapeutics against challenging drug targets, including GPCR’s, SLCs and Ion Channels.Stockholm, Sweden, September 07, 2022. – Salipro Biotech AB, a Swedish biotech company with a leading technology platform for the stabilization of membrane proteins for drug development, announced today that its patent entitled “Saposin lipoprotein particles and libraries from crude membranes” has been issued by both the U.S. Patent and Trademark Office (U.S. Patent No. 11,346,843B2)

Fidesmo partners with Infineon for accessibility of services to secure elements

Swedish company Fidesmo expands its partner network in Europe by joining forces with Infineon Technologie AG, a leading secure element manufacturer providing connectivity and security in the field of IoT, mobility and payments . The two companies now look to grow the availability of contactless services for Infineon’s secure elements. The partnership has already begun with creating a more flexible solution for payment wearables with more areas of cooperation to be explored.Fidesmo is specialized in providing scalable integrations between services and hardware manufacturers. Together with

Investment AB Latour has completed repurchase of shares

Investment AB Latour (publ) has on September 6, 2022, repurchased 100,000 class B shares (ISIN SE0010100958) for a price of SEK 205.80 per share. Latour's holding of own shares after the repurchase amounts to 514,900 class B shares. The total number of outstanding shares in the company is 639,325,100. The repurchase was completed on Nasdaq Stockholm by SEB on behalf of Latour. The purpose of the repurchase is to secure Latour's commitments to deliver shares in accordance with Latour's call option program. Göteborg, September 7, 2022 INVESTMENT AB LATOUR (PUBL)Johan Hjertonsson, CEO

CS MEDICA announces that their 6 CANNANSEN®CBD Medical Products has been successfully registered at MHRA for Sales in United Kingdom.

CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today that their 6 CANNANSEN® CBD Medical Products has been successfully registered at Medicines and Healthcare products Regulatory Agency ("MHRA") in United Kingdom. The 6 CANNANSEN® CBD Medical Products has been through a registration procedure at MHRA – the process is finalized and the products are now ready for Sale in United Kingdom.The registration of the 6 CANNANSEN® CBD medicinal products with the MHRA enables CS MEDICA to market and sell their 6 CANNANSEN® CBD medicinal products in the UK. The registration has further

BioStock: Swedish Hockey League taking concussion treatment seriously

Concussions are a serious, yet too often, underestimated issue in ice hockey. However, over the last few years, the Swedish Hockey League has been taking steps to give this problem more attention in the name of player safety, including the adoption of PolarCool’s concussion treatment PolarCap. BioStock reached out to IF Malmö Redhawks defenseman Markus Lauridsen to get a player’s perspective on the handling of concussions by the league and why PolarCap could be a gamechanger.Read the interview with Markus Lauridsen at biostock.se: Swedish Hockey League taking concussion treatment

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for August 2022

Oslo, Norway, September 7, 2022 Commercial update: In August 2022, the Company achieved average time charter equivalent earnings of approximately US$21,800 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$16,700 per day, gross, including average daily scrubber benefits of approximately US$4,000 per day. The Company’s two vessels trading on fixed time charter earned approximately US$37,000 per day, gross, including average daily scrubber benefits of approximately US$5,300 per day. The Baltic 5TC Capesize Index averaged US$9,339

Alzinova announces new positive safety review of its Phase 1b study in Alzheimer’s disease

Alzinova AB (publ) (“Alzinova” or “the Company”), announces today that a second external safety review has been carried out of the Company's clinical phase 1b study - with a positive assessment to continue the study as planned. Behind the review is an independent expert group, Data and Safety Monitoring Board ("DSMB"), which continuously reviews the study. Based on the patients included in the study, the DSMB recommends continuing the study as planned without adjustments. The Company has previously communicated DSMB’s first review in April 2022, which also gave the green light to continue the

There are no items matching the current filter
There are no more items matching the current filter
Back to top